Capetti Amedeo Ferdinando

Contacts

Altri numeri di telefono
3478436579
E-mail di ateneo
Office hours
Qualunque, dopo contatto telefonico o whatsapp
Luogo di ricevimento
Pad. 56 Malattie Infettive o Polo Lita
Research

Publications

  • Analyzing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicenter cohort of virologically-suppressed PLWHIV / A. Ciccullo, G. Baldin, G. Sterrantino, M.V. Cossu, A. Giacomelli, F. Lagi, D. Farinacci, V. Iannone, R. Anna Passerotto, A.F. Capetti, S. Antinori, C. Mussini, V. Borghi, S. DI GIAMBENEDETTO. - In: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. - ISSN 0305-7453. - 78:1(2023 Jan), pp. 117-121. [10.1093/jac/dkac362]
  • Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy / A. Rizzo, G. Pozza, F. Salari, A. Giacomelli, D. Mileto, M.V. Cossu, A. Mancon, G. Gagliardi, M. Bianchi, V. Micheli, A. Capetti, S. Antinori, M.R. Gismondo, P. Olivieri, A. Lombardi. - In: JOURNAL OF MEDICAL VIROLOGY. - ISSN 0146-6615. - 95:1(2023 Jan), pp. e28328.1-e28328.4. [10.1002/jmv.28328]
  • Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects / F. Borgonovo, C.A. Stangalini, C. Tinelli, C. Mariani, D. Mileto, M.V. Cossu, L. Abbati, L. Bilardo, G. Gagliardi, M. Cutrera, M. Pellicciotta, L. Armiento, G. Dedivitiis, A.F. Capetti, G. Rizzardini. - In: HUMAN VACCINES & IMMUNOTHERAPEUTICS. - ISSN 2164-5515. - 18:5(2022 Nov 30), pp. e2060018.1-e2060018.5. [10.1080/21645515.2022.2060018]
  • Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort / A. Ciccullo, G. Baldin, V. Borghi, F. Lagi, A. Latini, G. D'Ettorre, L. Oreni, P. Fusco, A. Capetti, M. Fabbiani, A. Giacomelli, A. Grimaldi, G. Madeddu, G. Sterrantino, C. Mussini, S. Di Giambenedetto. - In: VIRUSES. - ISSN 1999-4915. - 14:1(2022), pp. 163.1-163.6. [10.3390/v14010163]
  • One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG / A.F. Capetti, F. Borgonovo, D. Mileto, G. Gagliardi, C. Mariani, A. Lupo, G. Dedivitiis, P. Meraviglia, M. Pellicciotta, L. Armiento, M.V. Cossu, G. Rizzardini. - In: JOURNAL OF INFECTION. - ISSN 0163-4453. - 83:2(2021 Aug), pp. 241-244. [10.1016/j.jinf.2021.05.023]